<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A high remission rate (75%) was achieved in a preliminary study using bestatin in patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) </plain></SENT>
<SENT sid="1" pm="."><plain>One of 2 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t and 3 of 6 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> obtained complete response </plain></SENT>
<SENT sid="2" pm="."><plain>Two patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> achieved good response, but one with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> failed </plain></SENT>
<SENT sid="3" pm="."><plain>Clonogenic marrow cell culture studies in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> have demonstrated intrinsic hematopoietic stem cell abnormalities, in particular defective erythroid colony formation </plain></SENT>
<SENT sid="4" pm="."><plain>After bestatin treatment, these abnormalities as well as hematologic findings were markedly improved </plain></SENT>
<SENT sid="5" pm="."><plain>The results suggest that bestatin has an enhancing effect on burst promoting activity production of helper (CD4 positive) T lymphocytes and the effect on hematopoiesis of bestatin may be mediated by T lymphocytes </plain></SENT>
</text></document>